Sato K - Search Results

1

Salusins: potential use as a biomarker for atherosclerotic cardiovascular diseases.

Sato K, Watanabe R, Itoh F, Shichiri M, Watanabe T. Sato K, et al. Int J Hypertens. 2013;2013:965140. doi: 10.1155/2013/965140. Epub 2013 Oct 22. Int J Hypertens. 2013. PMID: 24251033 Free PMC article. Review.

2

The roles of salusins in atherosclerosis and related cardiovascular diseases.

Watanabe T, Sato K, Itoh F, Iso Y, Nagashima M, Hirano T, Shichiri M. Watanabe T, et al. Among authors: sato k. J Am Soc Hypertens. 2011 Sep-Oct;5(5):359-65. doi: 10.1016/j.jash.2011.06.003. J Am Soc Hypertens. 2011. PMID: 21925457 Review.

3

Emerging roles for vasoactive peptides in diagnostic and therapeutic strategies against atherosclerotic cardiovascular diseases.

Watanabe T, Sato K, Itoh F, Noguchi Y, Fujimoto K, Koyama T, Shichiri M. Watanabe T, et al. Among authors: sato k. Curr Protein Pept Sci. 2013 Sep;14(6):472-80. doi: 10.2174/13892037113149990064. Curr Protein Pept Sci. 2013. PMID: 23968353 Review.

4

Stimulatory effects of cardiotrophin 1 on atherosclerosis.

Konii H, Sato K, Kikuchi S, Okiyama H, Watanabe R, Hasegawa A, Yamamoto K, Itoh F, Hirano T, Watanabe T. Konii H, et al. Among authors: sato k. Hypertension. 2013 Nov;62(5):942-50. doi: 10.1161/HYPERTENSIONAHA.113.01653. Epub 2013 Sep 16. Hypertension. 2013. PMID: 24041953

5

Serum salusin-alpha levels are decreased and correlated negatively with carotid atherosclerosis in essential hypertensive patients.

Watanabe T, Suguro T, Sato K, Koyama T, Nagashima M, Kodate S, Hirano T, Adachi M, Shichiri M, Miyazaki A. Watanabe T, et al. Among authors: sato k. Hypertens Res. 2008 Mar;31(3):463-8. doi: 10.1291/hypres.31.463. Hypertens Res. 2008. PMID: 18497465

6

Pathogenic involvement of heregulin-β(1) in anti-atherogenesis.

Watanabe T, Sato K, Itoh F, Iso Y. Watanabe T, et al. Among authors: sato k. Regul Pept. 2012 Apr 10;175(1-3):11-4. doi: 10.1016/j.regpep.2012.01.004. Epub 2012 Feb 10. Regul Pept. 2012. PMID: 22331010 Review.

7

Endogenous bioactive peptides as potential biomarkers for atherosclerotic coronary heart disease.

Watanabe T, Sato K, Itoh F, Wakabayashi K, Shichiri M, Hirano T. Watanabe T, et al. Among authors: sato k. Sensors (Basel). 2012;12(4):4974-85. doi: 10.3390/s120404974. Epub 2012 Apr 18. Sensors (Basel). 2012. PMID: 22666071 Free PMC article. Review.

8

Vasoprotective effects of urocortin 1 against atherosclerosis in vitro and in vivo.

Hasegawa A, Sato K, Shirai R, Watanabe R, Yamamoto K, Watanabe K, Nohtomi K, Hirano T, Watanabe T. Hasegawa A, et al. Among authors: sato k. PLoS One. 2014 Dec 2;9(12):e110866. doi: 10.1371/journal.pone.0110866. eCollection 2014. PLoS One. 2014. PMID: 25462164 Free PMC article.

9

Counteractive effects of omentin-1 against atherogenesis†.

Watanabe K, Watanabe R, Konii H, Shirai R, Sato K, Matsuyama TA, Ishibashi-Ueda H, Koba S, Kobayashi Y, Hirano T, Watanabe T. Watanabe K, et al. Among authors: sato k. Cardiovasc Res. 2016 May 1;110(1):118-28. doi: 10.1093/cvr/cvw016. Epub 2016 Jan 19. Cardiovasc Res. 2016. PMID: 26790473

10

Contrasting effects of stanniocalcin-related polypeptides on macrophage foam cell formation and vascular smooth muscle cell migration.

Yamamoto K, Tajima Y, Hasegawa A, Takahashi Y, Kojima M, Watanabe R, Sato K, Shichiri M, Watanabe T. Yamamoto K, et al. Among authors: sato k. Peptides. 2016 Aug;82:120-127. doi: 10.1016/j.peptides.2016.06.009. Epub 2016 Jun 21. Peptides. 2016. PMID: 27346255

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

14,928 results

Search Page